Abstract
Purpose: To assess the efficacy of the BARD scoring system in Saudi non-alcoholic fatty liver disease (NAFLD) patients attending Gizan General Hospital and to identify the clinical variables associated with advanced fibrosis..
Methods: The cross-sectional study involved 120 patients aged >= 18 years who attended the Ultrasound Department of Gizan General Hospital, Gizan, Saudi Arabia, during January - June 2013. BARD scoring system comprised the following variables: body mass index (BMI) >= 28 = 1 point, aspartate aminotransferase/alanine aminotransferase (AST/ALT) ratio >= 0.8 = 2 points, and type 2 diabetes mellitus = 1 point.
Results: Patients with advanced fibrosis were older (55.0 years) than patients with no/mild fibrosis (48.6 years), albeit not significantly so. A higher BMI was associated with advanced fibrosis in males, females and all study participants (p = 0.013, 0.016 and 0.001, respectively). Advanced fibrosis was more common in older patients with a higher weight to height ratio. Logistic regression suggested that age >= 50 years was associated with a 2.52-fold increase in the risk of advanced fibrosis, but this did not have a significant clinical impact (p = 0.087). BMI > 28 was associated with a 26.73-fold increased risk of advanced fibrosis, while AST/ALT >= 0.8 was associated with an 18.46-fold increased risk of advanced liver fibrosis (p = 0.002 and 0.006, respectively).
Conclusion: The major risk factors for advanced fibrosis using BARD scoring system in patients with NAFLD were old age, BMI > 28, and AST/ALT >= 0.8. In addition, grade 3 ultrasonographic fatty liver significantly correlated with advanced fibrosis.